Hakan Hakkı TAŞKAPU, Mehmet Giray SÖNMEZ, Gökhan ECER, Muzaffer Tansel KILINÇ, Süleyman BATDIK, Ahmet ÖZTÜRK

4 mm’lik testis tümörüne ultrason eşliğinde işaretleme ile organ koruyucu cerrahi

Testis kanseri 15–45 yaş arası erkeklerde en sık görülen malignitedir. Ultrasonun yaygın kullanımıyla birlikte küçük asemptomatik testisküler kitlelerin tanısında da artış olmuştur. Radikal orşiektomi testis kanserinin standart tedavisi olmasına karşın; son yıllarda bilateral testis kanseri ve küçük testiküler kitlelerin tedavisinde umut verici onkolojik ve fonksiyonel sonuçları nedeniyle testis koruyucu cerrahinin yeri artmıştır. 2 cm’den küçük testis kitlelerinde uygun hastalara testis koruyucu tedavi yapılabilmesi önerilmektedir. Fakat kitlenin küçük olması cerrahi sırasında bulunabilirliği ve eksizyonu zorlaştırmaktadır. Literatürde özellikle küçük testis tümörleri için organ koruyucu tekniği gösteren az sayıda yayın vardır. Bizde 4 mm çaplı oldukça küçük testis tümörü olan hasta da yaptığımız parsiyel orşiektomi olgusunu ve kullandığımız tekniği paylaşmak istedik.

Organ preserving surgery with ultrasound-guided marking in 4 mm testicular tumor

Testicular cancer is the most common malignity seen in males between the ages of 15 and 45. There has been an increase in the diagnosis of small asymptomatic testicular masses with extensive ultrasound use. Although radical orchiectomy is the standard treatment for testicular cancer, the importance of testicle preserving surgery has increased in recent years due to its promising oncological and functional results in the treatment of bilateral testicle cancer and small testicular masses. Testicle preserving treatment is suggested for testicular masses smaller than 2 cm in suitable patients. But small mass size makes the detectability and excision harder during the surgery. In literature, there are limited publications demonstrating organ preserving technique especially for small testicular tumors. Our aim was to share the partial orchiectomy case which had a quite small testicular tumor with a diameter of 4 mm and the technique we used for this case.

PDF

___

1. Manecksha RP, Fitzpatrick JM. Epidemiology of testicular cancer. BJU Int 2009;104:1329–33. [CrossRef]
2. Dieckmann KP, Frey U, G Lock. Contemporary diagnostic workup of testicular germ cell tumours. Nat Rev Urol 2013;10:703–12. [CrossRef]
3. Carmignani L, Gadda F, Gazzano G, Nerva F, Mancini M, Ferruti M, et al. High incidence of benign testicular neoplasm diagnosed by ultrasound. J Urol 2003;170:1783–86. [CrossRef]
4. Bumbasirevic U, Bojanic N, Pekmezovic T, Janjic A, Janicic A, Milojevic B, Tulic C. Health-related quality of life, depression, and sexual function in testicular cancer survivors in a developing country: A Serbian experience. Support Care Cancer 2013;21:757–63. [CrossRef]
5. Giannarini G, Dieckmann KP, Albers P, Heidenreich A, Pizzocaro G. Organ-sparing surgery for adult testicular tumours: A systematic review of the literature. Eur Urol 2010;57:780–90. [CrossRef]
6. Borghesi M, Brunocilla E, Schiavina R, Gentile G, Dababneh H, Della Mora L, et al. Role of testis sparing surgery in the conservative management of small testicular masses: Oncological and functional perspectives. Actas Urol Esp 2015;39:57–62. [CrossRef]
7. Lawrentschuk N, Zuniga A, Grabowksi AC, Rendon RA, Jewett MA. Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: A large North American experience. J Urol 2011;185:508–13. [CrossRef]
8. Bojanic N, Bumbasirevic U, Vukovic I, Bojanic G, Milojevic B, Nale D, et al. Testis sparing surgery in the treatment of bilateral testicular germ cell tumors and solitary testicle tumors: A single institution experience. J Surg Oncol 2015;111:226–30. [CrossRef]
9. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011;60:304–19. [CrossRef]
10. Kabay Ş, İşler B, Sevim M. Testis Sparing Surgery Indications. Bull Urooncol 2015;14:235–7. [CrossRef]
11. Göktaş S, Zorba OÜ. Testis tümörlerinde organ koruyucu cerrahi. Uronkoloji Bülteni 2009;3:52–8. http://cms.galenos.com.tr/ Uploads/Article_8431/52-58.pdf
12. Shilo Y, Zisman A, Raz O, Lang E, Strauss S, Sandbank J, et al. Testicular sparing surgery for small masses. Urol Oncol 2012;30:188–91. [CrossRef]
13. Ates F, Malkoc E, Zor M, Demirer Z, Alp BF, Basal S, et al. TestisSparing surgery in small testicular masses not suspected to be malignant. Clin Genitourin Cancer 2016;14:e49–53. [CrossRef]
14. Park SB, Lee WC, Kim JK, Choi SH, Kang BS, Moon KH, et al. Imaging features of benign solid testicular and paratesticular lesions. Eur Radiol 2011;21:2226–34. [CrossRef]
15. Silverio PC, Schoofs F, Iselin CE, Tille JC. Fourteen-year experience with the intraoperative frozen section examination of testicular lesion in a tertiary university center. Ann Diagn Pathol 2015;19:99–102. [CrossRef]
16. Leroy X, Rigot JM, Aubert S, Ballereau C, Gosselin B. Value of frozen section examination for the management of nonpalpable incidental testicular tumors. Eur Urol 2003;44:458–60. [CrossRef]
17. Favilla V, Russo GI, Spitaleri F, Urzì D, Madonia M, La Vignera S, et al. Prevalence of intratubular germ cell neoplasia and multifocality in testicular germ cell tumors< 2cm: Relationship with other pathological features. Clin Genitourin Cancer 2015;13:e31–5. [CrossRef]
18. Bojanic N, Bumbasirevic U, Bojanic G, Vukovic I, Milojevic B, Pekmezovic T. Testis Sparing Surgery for Treatment of Small Testicular Lesions: Is It Feasible Even in Germ Cell Tumors? J Surg Oncol 2017;115:287–90. [CrossRef]
19. Pierconti F, Martini M, Grande G, Larocca LM, Sacco E, Pugliese D, et al. Germ Cell Neoplasia in situ (GCNIS) in TestisSparing Surgery (TSS) for Small Testicular Masses (STMs). Front Endocrinol (Lausanne) 2019;10:512. [CrossRef]
20. Ye JF, Wang B, Ma LL, Zhao L, Wang GL, Hong K. Organ-sparing partial orchietectomy for testicular adenomatoid tumor. Beijing Da Xue Xue Bao Yi Xue Ban 2019;51:365–8. http://xuebao.bjmu. edu.cn/EN/Y2019/V51/I2/365
21. Xiao F, Shi JZ, Liu Y, Liu T, Wang J, Liu YS, et al. Radical and testis-sparing surgery for primary testicular tumors: A single-center experience. Mol Clin Oncol 2019;10. [CrossRef]
22. La Rocca R, Capece M, Spirito L, Cumberbatch MK, Creta M, Altieri V, et al. Testis-sparing surgery for testicular masses: current perspectives. Minerva Urol Nefrol 2019;71:359–64. [CrossRef]
23. Heidenreich A, Weissbach L, Holtl W, Albers P, Kliesch S, Köhrmann KU, et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001;166:2161–5. [CrossRef]
24. Behre K, Kliesch S, Leifke E, Link TM, Nieschlag E. Longterm effect of testosterone therapy on bone mineral density in hypogonodal men. J Clin Endocrinol Metab 1997;82:2386–90. [CrossRef]